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Abstract
A reduction in functional b-cell mass leads to both major forms of diabetes; pro-inflammatory cytokines, such as interleukin-
1beta (IL-1b) and gamma-interferon (c-IFN), activate signaling pathways that direct pancreatic b-cell death and dysfunction.
However, the molecular mechanism of b-cell death in this context is not well understood. In this report, we tested the
hypothesis that individual cellular death pathways display characteristic phenotypes that allow them to be distinguished by
the precise biochemical and metabolic responses that occur during stimulus-specific initiation. Using 832/13 and INS-1E rat
insulinoma cells and isolated rat islets, we provide evidence that apoptosis is unlikely to be the primary pathway underlying
b-cell death in response to IL-1b+c-IFN. This conclusion was reached via the experimental results of several different
interdisciplinary strategies, which included: 1) tandem mass spectrometry to delineate the metabolic differences between
IL-1b+c-IFN exposure versus apoptotic induction by camptothecin and 2) pharmacological and molecular interference with
either NF-kB activity or apoptosome formation. These approaches provided clear distinctions in cell death pathways
initiated by pro-inflammatory cytokines and bona fide inducers of apoptosis. Collectively, the results reported herein
demonstrate that pancreatic b-cells undergo apoptosis in response to camptothecin or staurosporine, but not pro-
inflammatory cytokines.
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Introduction
Type 1 diabetes mellitus is an autoimmune disease that occurs
when pancreatic b-cells within the islets of Langerhans are
selectively destroyed by resident and invading immune cells [1].
The initial trigger for onset of this process is unknown. However,
leukocyte secretion of pro-inflammatory cytokines, such as IL-1b
and c-IFN, is a critical factor in the destruction of islet bcells [2].
IL-1b induces the expression of several genes that produce
inflammatory mediators, including inducible nitric oxide synthase
(iNOS); the intracellular production and accumulation of nitric
oxide impairs b-cell function and decreases viability in both rodent
and human islets and b-cell lines [3,4,5]. While the toxic effects of
pro-inflammatory cytokines have been known for decades [6,7,8],
the mechanism underlying b-cell death in response to these
cytokines is not well understood; delineating the pathway(s) of b-
cell death in response to pro-inflammatory cytokines is essential for
targeting precise and robust strategies for protection against losses
in functional b-cell mass. Currently, b-cell death in response to IL-
1b and c-IFN has been suggested to proceed through either
necrosis [9,10,11] or apoptosis [12,13].
Apoptosis is a form of programmed cell death classically
described by morphological changes that include rounding of
cells, changes to membrane and cytoskeletal structure, and DNA
fragmentation [14]. These alterations occur through the
biochemical actions of a cysteine aspartate protease family of
enzymes called caspases, which are usually present as inactive
zymogens that require proteolytic processing in response to a
particular stimulus to become active [15]. Activation of
executioner caspases, such as caspase-3, results from the
assembly and processing of initiator caspases (e.g., caspase-9) in
response to a signal, such as DNA damage. Part of this caspase
activation process relies on oligomerization of the pro-apoptotic
proteins Bak and Bax, which releases cytochrome c into the
cytoplasm via permeabilization of mitochondrial membranes
[16]. Cytosolic cytochrome c then interacts with APAF-1 and
caspase-9 to form the apoptosome, a large protein complex
which also contains dATP [17]; the apoptosome processes pro-
caspase-9 to active caspase-9, which then proteolytically cleaves
caspase-3. Cleaved (active) caspase-3 targets a large number of
intracellular substrate proteins for degradation, leading to
cellular termination. Once the apoptotic cascade has been
initiated, multiple cellular targets are cleaved by executioner
caspases in a highly organized, ATP-dependent manner [15].
Because of the efficient nature of this pathway, apoptosis is the
usual method by which metazoans replace damaged or
unwanted cells during normal growth and development;
consequently, this cellular death mechanism is usually associated
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responses [15,18].
Alternatively, cells undergoing necrosis display losses in plasma
membrane integrity, declining ATP levels, and tend to provoke
inflammatory responses [18,19]. A number of pro-inflammatory
signals, including IL-1b, produce inflammation via activation of
the NF-kB pathway [20], which is a dimer consisting of various
combinations of five different DNA-binding subunits: p65 (RelA),
RelB, c-Rel, p50 and p52.The activity of these transcription
factors is regulated at multiple levels, including cytoplasmic
retention by the inhibitors of kappa B (IkB) proteins [21]. IL-1b
activates the interleukin receptor type I at the cell surface, leading
to recruitment of receptor adaptor proteins, and signaling through
various kinases, including the IkB kinases (IKKs). The IKKs
phosphorylate the IkB proteins, promoting their degradation and
releasing NF-kB proteins to translocate from the cytoplasm to the
nucleus. Once in the nucleus, the different NF-kB subunits can
hetero- and homo-dimerize to transactivate a multitude of genes
(e.g., iNOS) involved in inflammatory responses that lead to tissue
dysfunction and cell death [5,22]. Release of cellular contents via
this type of death mechanism can activate immune cell responses.
Thus, dying cells are managed differently by the immune system
depending on whether they are undergoing apoptosis or necrosis
[19,23,24,25].
The present study was undertaken to investigate the mechanism
of b-cell death in response to pro-inflammatory cytokines.
Currently, the accepted means of defining necrotic cell death is
to demonstrate that apoptosis is not occurring [18]. Towards this
end, we have previously demonstrated that interference with pro-
and anti-apoptotic proteins impacts b-cell viability in response to
true apoptotic signals, but has no effect on pro-inflammatory
cytokine-mediated cell death [11]. Alternatively, other studies have
suggested an activation of the intrinsic pathway of apoptosis by
cytokines [13]. Therefore, to further address the mechanism
underlying b-cell death in response to cytokines, we have taken the
following approaches: 1) temporal- and concentration-dependent
investigation of the biochemical effects of pro-inflammatory
cytokines vs. bona fide inducers of apoptosis ; 2) a tandem mass
spectrometry based metabolomics study to quantitate the meta-
bolic signatures produced by the pro-inflammatory cytokines IL-
1b and c-IFN as compared to camptothecin, a bona fide apoptotic
inducer; 3) pharmacological and molecular inhibition of signaling
through the NF-kB pathway; and 4) manipulation of the
apoptosome components APAF-1 and caspase-9. Collectively,
the results reported herein confirm and extend previous
observations [9,10,11] that apoptosis is not the major mechanism
of b-cell death in response to pro-inflammatory cytokines.
Materials and Methods
Cell Culture, Adenoviral Vectors, Nitrite and Viability
All animal work was performed in accordance with procedures
approved by the Duke University IACUC in appropriately
accredited facilities (Animal Protocol # A309-10-12). Culture of
the INS-1-derived 832/13[26] and INS-1E [27] cell lines have
been described. Islets were isolated as described [11]. Recombi-
nant adenoviruses expressing bGAL [28], IkBa S32/36A [29] and
caspase-9 dominant-negative [30] have all been described.
Recombinant adenovirus expressing a luciferase gene under the
control of a multimerized NF-kB promoter was a gift from Dr.
Michael Karlstad (University of Tennessee Graduate School of
Medicine). Nitrite production and viability measured by both
MTS and adenylate kinase release have been described previously
[11].
Caspase 3 Enzymatic Activity
Whole cell lysates were collected using radioimmunoprecipita-
tion assay (RIPA) buffer and analyzed for caspase -3 enzyme
activity using Caspase Glo substrate (Promega) and a GloMax
plate reader (Promega) according to manufacturer’s protocol.
Transfection of siRNA Duplexes
832/13 cells were transfected with pre-annealed siRNA
duplexes (siAPAF: siRNA ID# 52648) from Ambion/Applied
Biosytems using DharmaFECT reagent 1 (Dharmacon) according
to the manufacturer’s protocol. Suppression of target genes was
analyzed by real-time RT-PCR detection of mRNA levels and
functional outcome.
Isolation of Protein and Immunoblot Analysis
Whole cell lysates were harvested using the M-PER lysis buffer
(Pierce). Protein concentration was determined via BCA assay
(Pierce) using bovine serum albumin as the standard. Immuno-
blotting was performed as described previously [11,31]. Antibodies
were from Santa Cruz Biotechnology (IkBa), Cell Signaling
(caspase-3) and Sigma (tubulin and b-Actin).
Isolation of RNA, cDNA Synthesis and Real-time RT-PCR
Total RNA was isolated from cells using Isol-RNA Lysis
Reagent (5 Prime) according to the manufacturer’s protocol. Verso
cDNA synthesis kit (Thermo Scientific) was used for first-strand
synthesis of cDNA using 0.5 mg of RNA. For real-time PCR
measurements of relative mRNA abundance, 2.5% of the total
reverse transcriptase (RT) reaction was used with Taqman
primer/probe sets (Applied Biosystems; siAPAF1 Cat#
Rn0057683) and ABsolute Blue QPCR Master Mix (Thermo
Scientific). Real-time RT-PCR was performed using the Applied
Biosystems Prism 7300 sequence detection system and software.
Relative mRNA levels for individual genes were normalized to
either cyclophilin or ribosomal S9.
Sample Preparation for Mass Spectrometric Analysis
832/13 cells were grown to confluence in 15 cm dishes and
treated as indicated in the figure legends. At the end of the
treatment period, cells were washed twice with ice cold PBS,
scraped and pelleted at 5006g; the aspirated dry cell pellets were
immediately flash frozen using liquid N2. Four individual
experiments were performed in duplicate on each of 3 days. Prior
to extraction, the collected cell pellets were weighed, and 30–
50 mg of each was placed into a microcentrifuge tube at 278uC.
A solution of cold methanol and water (8:2 v/v, 1.5 mL) kept at
280uC was then added to the tube to extract the metabolome
from the cells. The contents were mixed by vortexing and allowed
to sit at the extraction temperature for 20 min. Particulates were
then removed from the samples by centrifugation, and the
supernatants were transferred to autosampler vials for further
analysis by the LC-MS/MS methods described below.
Chromatographic Separation Methods
High performance liquid chromatographic (HPLC) separation
of the metabolites was performed via a slight modification of
previously reported methods [32,33]. Details for these techniques
are as follows: A quaternary pump was used to generate a gradient
for the elution of compounds from the stationary phase. In total,
two HPLC runs are necessary to fully characterize the metabo-
lome for each sample since separate detection for positively
ionizing and negatively ionizing compounds is required. For all
samples, 10 mL was injected onto the column via an Finnigan
Mechanisms of Pancreatic b-Cell Death
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positive mode analyses, a Luna 5 m NH2 100 A ˚ HILIC column
(25062.00 mm, 5 m) (Phenomenex, Torrance, California) was
used. The mobile phase flow rate was 150 mL/min, and a gradient
of two solvents was used for elution. Solvent A was a mixture
composed of 95% 20 mM ammonium acetate, 20 mM ammoni-
um hydroxide in HPLC grade water buffered at pH=9.4 with 5%
HPLC grade acetonitrile. Solvent B was pure HPLC grade
acetonitrile. These were used to construct the following 40 min
gradient elution profile: t) 0 min, 15% solvent A, 85% solvent B; t)
15 min, 100% solvent A, 0% solvent B; t) 28 min, 100% solvent A,
0% solvent B; t) 30, 15% solvent A, 85% solvent B; t) 40, 15%
solvent A, 85% solvent B. Separations were performed with the
column temperature set at 10uC. For negative mode analyses, a
Synergi 4 m Hydro-RP 80 A ˚ C18 column (15062.00 mm, 4 m)
(Phenomenex, Torrance, California) was used. The mobile phase
flow rate was 200 mL/min, and a gradient of two solvents was again
used for elution. Solvent A consisted of a mixture containing 97%
11 mMtributylamine and 15 mM aceticacid in HPLC grade water
and 3% HPLC grade methanol. Solvent B was pure HPLC grade
methanol. These were used to construct the following 50 min
gradient elution profile: t) 0 min, 100% solvent A, 0% solvent B; t)
5 min, 100% solvent A, 0% solvent B; t) 10 min, 80% solvent A,
20% solvent B; t) 15, 80% solvent A, 20% solvent B; t) 30, 35%
solvent A, 65% solvent B; t) 33, 5% solvent A, 95% solvent B; t )3 7 ,
5% solvent A, 95%solvent B; t) 38, 100% solvent A, 0% solvent B; t)
50, 100% solvent A, 0% solvent B. Separations were performed
with the column temperature maintained at 25uC. For both positive
and negative mode analyses, the eluent was introduced directly into
the MS for ion detection.
Mass Spectrometric Detection Parameters
Samples were introduced into the electrospray ionization (ESI)
chamber of a Finnigan TSQ Quantum Discovery Max triple
quadrupole MS (Thermo Electron) through a 0.1 mm internal
diameter fused silica capillary after delivery by HPLC as described
above. The spray voltage for the ESI source was set to 4500 V, if
detection occurred in positive ion mode If detection occurred in
negative mode, the spray voltage for the ESI source was set to
3000 V. Nitrogen was used as the sheath gas (40 psi), and the inlet
capillary temperature was 290uC. Argon was used as the collision
gas at a pressure of 1.5 mTorr. Samples were analyzed using
selected reaction monitoring (SRM) with the scan time for each
SRM set to 0.05 s and a scan width of 1 m/z. Full selected
reaction monitoring (SRM) detection parameters for most
compounds have been previously reported by Rabinowitz and
coworkers [33].
Metabolomics Data Handling
Raw files from each sample were processed using the Xcalibur
MS analysis software (Thermo Electron, Waltham, Massachusetts).
The peak for each detected metabolite was manually integrated to
determine the peak area using the Quan Browser function of
Xcalibur. The integration values were then directly entered into a
Microsoft Excel spreadsheet where they were normalized to the
mass of tissue extracted. Since inter-day variability in the ion counts
for metabolites was observed due to MS sampling variation, the
treated samples were compared only to the control samples run on
the same day. This comparison consisted of averaging the ion
counts for the duplicate measurements of a metabolite from a
treated sample on a given day and then dividing this number by the
average of the duplicate measurements of the same metabolite from
the control sample obtained on the same day to generate the fold
change for the compound. The fold changes for the metabolite from
each of the three days were then averaged and displayed in heat
map format and clustered using the freely available Cluster 3.0
(www.falw.vu/,huik/cluster.htm) and Java Treeview [34] data
analysis packages.
Statistical Analyses
A one-way ANOVA (GraphPad Prism) was performed to detect
statistical differences within all biochemical assays. Differences
within the ANOVA were determined using a Tukey post hoc test.
All data are reported as means 6 SEM. For statistical analysis of
data acquired using the aforementioned mass spectrometry
techniques, the p value for each metabolite fold change was
obtained by performing an F-test using the data analysis tool pack
in Microsoft Excel. The variance in the fold changes for the
metabolites in the treatment group was compared to a set of
standardized fold changes for the metabolites from the control
group that was generated by taking the intra-day ratio of the ion
counts from the duplicate measurements of the control.
Results
INS-1E and 832/13 Rat Insulinoma Cells Display Similar
Sensitivities to Pro-inflammatory Cytokines or Genuine
Apoptotic Inducers
832/13[26] and INS-1E[27] cellswerederived from theoriginal
INS-1 population [35] by distinct selection protocols. It was
hypothesized previously that G418 selection of 832/13 cells from
the parental INS-1 population might impair the sensitivity of this
cell line to the effects of IL-1b and c-IFN [13]. To directly test this
possibility, we investigated the sensitivity of the two aforementioned
INS-1-derived cell lines to IL-1b and c-IFN as well as to bona fide
inducers of apoptosis. Exposure to 1 ng/mL IL-1b+100 U/mL c-
IFN (18 h) generated 16.8-fold (832/13) and 9.9-fold (INS-1E)
nitrite accumulationinthe media(Figure1A),whichcorrelated with
66.7%and 42%decreasesinviabilityasmeasuredbymitochondrial
reductionof[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphe-
nyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)] (Figure 1B and C). In
addition,releaseofadenylatekinase(ADK)into themedia,a second
independent measure of viability [11], confirmed the results seen
with MTS assays (Figure 1D and E). From these results, it is clear
that both of these INS-1-derived cell lines display robust sensitivity
to IL-1b+c-IFN, which has not been reported previously. Next, we
selected two different inducers of apoptosis based on their known
mechanisms of action: camptothecin (CPT), a topoisomerase I
inhibitor, and staurosporine (STS), a general protein kinase
inhibitor. Using 2 mM CPT and 1 mM STS, we observed similar
lossesinviabilityinboth 832/13 andthe INS-1Ecelllines;however,
exposure to these compounds did not lead to the production of
nitrite (Figure 2A), demonstrating a key distinction in mechanism of
killing between pro-inflammatory cytokines and apoptotic inducers,
consistent with previous reports [9,11]. Thus, 832/13 and INS-1E
cells display comparative sensitivities to pro-inflammatory cytokines
and apoptotic agents, despite distinct selection strategies used to
obtain these clonal cell lines.
It has been postulated that the dose of cytokines might
determine which cell death pathway is preferentially activated
[13]. To test this hypothesis, we examined the effects of adding
three different concentrations of IL-1b (0.01, 0.1, and 1 ng/mL) to
both 832/13 and INS-1E cell lines to determine whether or not
the concentration of pro-inflammatory cytokines selects for
apoptosis or necrosis in b-cells. While there was a clear dose-
dependent increase in nitrite production with IL-1b (Figure 2A),
showing that the cells are capable of responding to different doses
of cytokines, there was no significant caspase-3 enzymatic activity
Mechanisms of Pancreatic b-Cell Death
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22485Figure 1. INS-1E and 832/13 rat insulinoma cells both display sensitivity to pro-inflammatory cytokines and genuine apoptotic
inducers. 832/13 and INS-1E cells were exposed to either media alone (No Tx), 1 ng/mL IL-1b+100 U/mL c-IFN for 18 h, 2 mM camptothecin for 6 h
or 1 mM staurosporine for 6 h. A. Nitrite accumulation was measured by the Griess assay. Cell viability was measured by both MTS assay (B and C), and
adenylate kinase assay (D and E). Data are means 6 SEM for three individual experiments. #, p=0.05 vs. control; * p,0.05 vs. control; **, p,0.01 vs.
control.
doi:10.1371/journal.pone.0022485.g001
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trations of STS were increased, there was a corresponding dose-
dependent enhancement in caspase-3 activity (Figure 2B); CPT
also augmented caspase-3 activity similarly at all concentrations
examined in this study (Figure 2B). We noted that pro-
inflammatory cytokines and bona fide inducers of apoptosis all
led to cellular demise as measured by MTS and ADK (Figure 2C
and D). Our results are therefore consistent with a previous report
in human islets where doses of IL-1b similar to those used here did
not induce apoptosis [36] and with other existing evidence that
nitric oxide accumulation prevents activation and activity of
caspases [37,38,39].
Because apoptosis occurs rapidly in response to a particular
stimulus, we measured the temporal aspects of pro-inflammatory
cytokines versus inducers of apoptosis in both 832/13 and INS-1E
b-cell lines over 6 h. Note that while nitrite accumulates at 6 h in
the presence of IL-1b+c-IFN (Figure 3A), which demonstrates
clear evidence of cytokine action, there is no attendant increase in
caspase-3 enzyme activity (Figure 3B). Conversely, CPT and STS
induced a time-dependent 5.7-fold and 7.6-fold increase in
caspase-3 enzyme activity at 6 h (Figure 3B). In all cases of true
apoptotic induction, augmentation of caspase-3 activity correlated
with losses in viability, as measured by both the MTS and ADK
assays (Figure 3C and D). We note that while a 6 h exposure to IL-
Figure 2. Pro-inflammatory cytokines have a dose-dependent effect on INS-1-derived cell lines. 832/13 cells were treated with standard
culture media as a control (No Tx), increasing concentrations of IL-1b (0.01, 0.1, and 1 ng/mL) for 18 h, camptothecin (0.5, 1, and 2 mM) for 6 h or
staurosporine (0.25, 0.5, 1 mM) for 6 h. Nitrite accumulation (A), caspase 3 enzyme activity (B), cell viability via MTS (C) or adenylate kinase release (D)
were measured. Data represent means 6 SEM for three individual experiments. *, p,0.05 vs. control; **, p,0.01 vs. control.
doi:10.1371/journal.pone.0022485.g002
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increased nitrite production, this timing was adequate to reduce
glucose-stimulated insulin secretion (JJC, unpublished observa-
tion). Our current observations are therefore consistent with
studies in both rat and human islets [9,11].
Metabolic profiling by Tandem Mass Spectrometry
Reveals Distinct Metabolite Responses of Cells Exposed
to Pro-inflammatory Cytokines vs. the Apoptotic Inducer
Camptothecin
While pro-inflammatory cytokines and genuine inducers of
apoptosis are both capable of decreasing viability (See Figures 1–3
and [9,11]), we hypothesized that they do so via different
mechanisms. Thus, to further compare these cellular death
effectors, we used a metabolomic tandem mass spectrometric
approach to investigate metabolite changes that occur in response
to either IL-1b+c-IFN or CPT in 832/13 cells. The rationale for
this comparison was that since nitric oxide accumulation produces
DNA damage [40] via production of micromolar amounts of
intracellular nitric oxide [4,5], while CPT triggers apoptosis
through DNA damage generated by topoisomerase inhibition
[41], different metabolic pathways would be used depending on
the mechanism of cell death. Concentration changes in ,90
metabolites generated by these distinct stimuli measured relative to
their respective control groups are displayed in heatmap form
(Figure 4A), and these data reveal a discrete pattern of metabolites
that change in a stimulus-specific pattern (e.g., IL-1b+c-IFN vs.
CPT).
For example citrulline, an end product of the inducible nitric
oxide synthase reaction [42], accumulates approximately 400-fold
(see Table S1); this is fitting with nitrite production observed upon
Figure 3. Time-dependent sensitivity of INS-1-derived cell lines in response to pro-inflammatory cytokines and bona fide apoptotic
inducers. 832/13 cells were treated with media alone (No Tx), 1 ng/mL IL-1b plus 100 U/mL c-IFN, 2 mM camptothecin or 1 mM staurosporine for 1.5,
3, and 6 h. Measurements of nitrite (A), caspase 3 enzyme activity (B), cellular viability via MTS (C) and adenylate kinase (D) were analyzed. Data are
means 6 SEM for three individual experiments. *, p,0.05 vs. control.
doi:10.1371/journal.pone.0022485.g003
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an internal control for cytokine efficacy (note that there is no
increase in citrulline with CPT – see Table S2). Therefore, we
believe that these data are sufficient to conclude that while both
types of stimuli (i.e., cytokines and CPT) generate losses in cellular
viability [see [9,11] and Figures 1–3], the metabolic profile of each
specific stimulus is visibly distinct.
Since CPT and IL-1b+c-IFN produced discrete metabolic
profiles (Figure 4A and Tables S1 and S2), we examined the
possibility that metabolites altered during apoptosis were poten-
tially interfering with the actions of pro-inflammatory cytokines.
From the metabolomic data, it was noted that the 59-deoxy-59-
methylthioadenosine (MTA) concentration was higher in cells
treated with CPT than in those exposed to IL-1b+c-IFN. MTA is
involved in the biosynthesis of polyamines, a group of compounds
that are associated with DNA synthesis and replication [43] and in
controlling NF-kB activity through monomethylation of the p65
subunit [44]. To examine the effects of either CPT or MTA on
NF-kB activity, we transduced 832/13 and INS-1E cells with a
recombinant adenovirus that contains a luciferase reporter gene
driven by multiple NF-kB elements (Figure 4B). IL-1b increased
the activity of this reporter gene construct by 24-fold. CPT
exposure, which promoted MTA accumulation (Figure 4A),
decreased IL-1b-mediated induction of the NF-kB promoter
activity by 39% (Figure 4B). To examine whether direct MTA
addition has effects similar to that of CPT, we added exogenous
MTA to both INS-1E and 832/13 cells and observed a dose-
dependent decrease in the activity of the same NF-kB luciferase
reporter construct in both cell lines (Figure 4C and D). In addition,
direct MTA addition inhibited cytokine-mediated nitrite produc-
tion (Figure 4E), which fits with its effects on NF-kB promoter
activity. Thus, the current results are consistent with pro-
inflammatory cytokines and apoptotic inducers activating distinct
pathways in pancreatic b-cells and with MTA accumulation
during apoptosis interfering with NF-kB activity.
Molecular or Pharmacological Interference with NF-kB
Activity Protects against Cytokine-Mediated Cell Death
but not Apoptosis
To further test the hypothesis that IL-1b+c-IFN require discrete
pathways to mediate their cytotoxic effects as compared to known
inducers of apoptosis, we examined whether interference with the
NF-kB signaling pathway impacted cellular responses to each of
these stimuli. The IkB kinases (IKKs) control phosphorylation of
both the inhibitory IkB proteins and the p65 subunit of NF-kB
dimers and therefore serve as a convergence point for inflamma-
tory stimuli, such as IL-1b that activate NF-kB [21]. Therefore, we
used the pharmacological inhibitor of IKKb, 2-[(Aminocarbony-
l)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA) to
examine whether interference with a critical kinase in the NF-
kB signaling pathway offered protection against pro-inflammatory
cytokines or bona fide inducers of apoptosis. Using adenoviral
delivery of an NF-kB driven luciferase reporter gene in 832/13
and INS-1E cells, we observed that TPCA inhibited cytokine-
mediated induction of NF-kB activity (Figure 5A and B) and nitrite
accumulation in a dose-dependent fashion (Figure 5C and D).
Next, we measured the effects of TPCA treatment on viability in
response to cellular exposure with either IL-1b+c-IFN or CPT. In
both 832/13 and INS-1E cells, TPCA provided significant
protection as measured by the MTS assay (41 and 49% increase,
respectively) against the pro-inflammatory cytokines but not to
CPT (Figure 5E and 5F). Similar results were obtained with
adenylate kinase release (data not shown). Our results are
consistent with existing studies demonstrating anti-inflammatory
effects for this compound in other systems [45] and reveal the
involvement of b-cell IKKbin mediating the toxic effect of
cytokines.
Next, we took a different approach to interfering with NF-kB
activity by examining how a mutant version of IkBa, termed the
IkBa super-repressor (IkBa SR), would impact cellular survival in
response to pro-inflammatory cytokines and apoptotic inducers.
The IkBa SR contains amino acid substitutions (S32A/S36A) that
prevent degradation by the usual inflammatory signals that
activate NF-kB [29]. Expressing this mutant IkBa protein using
recombinant adenovirus in 832/13 cells increased total IkBa
abundance (Figure 6A), which yielded a 69% decrease in IL-1b-
mediated NF-kB promoter activity (Figure 6B) and a correspond-
ing 52% decrease in nitrite production (Figure 6C); these
observations correlate with a 34.3% increase in viability in 832/
13 cells expressing the IkBa SR when compared to cells receiving
b-galactosidase, a control for adenoviral transduction (Figure 6D).
However, this maneuver was unable to prevent b-cell death in
response to STS (Figure 6D). Taken together, these results are
consistent with the requirement for NF-kB during cytokine-
mediated b-cell death, but not to cellular demise in response to
bona fide apoptotic induction.
Manipulation of the Apoptosome Protects against
Apoptosis but does not Impact Pro-inflammatory
Cytokine-mediated Cell Death
Processing of caspase-9 from an inactive form to an active form
occurs via interaction with a large protein complex called the
apoptosome, which also consists of cytochrome c, dATP, and
APAF-1 [46]. To address whether interfering with the activity of
this complex protects against cytokine-mediated cell death or
apoptosis or both, we used siRNA-directed suppression of APAF-
1, expression of a dominant-negative caspase-9, or a combination
of these approaches. The dominant-negative caspase-9 (C9DN)
contains the caspase activation recruitment domain, but no
catalytic domain, and thus is incorporated into the apoptosome
but does not possess enzymatic activity and therefore does not
process downstream pro-caspases [30]. Expression of the C9DN
Figure 4. Metabolic profiling by tandem mass spectrometry reveals distinct metabolite signatures of cells exposed to pro-
inflammatory cytokines vs. the apoptotic inducer camptothecin. A. 832/13 cells were exposed to 1 ng/mL IL-1b+100 U/mL c-IFN or 2 mM
camptothecin for 6 h. Metabolite concentration was measured by mass spectrometry with values displayed as fold change relative to control. The
represent values given in log2, so that ‘‘3.00’’ is a minimum of an 8-fold increase, while ‘‘23.00’’ is a minimum of an 8-fold decrease. The red color
indicates a metabolite increase in the treatment condition relative to an untreated control, while the green color represents a decrease relative to
control. The p values for all metabolites are given in Tables S1 and S2. B. 832/13 cells were transduced with recombinant adenovirus expressing a
luciferase reporter gene driven by three NF-kB response elements (NF-kB-luc). After 24 h, cells were cultured in increasing concentrations of
camptothecin (0.5, 1, 2 mM) for 1 h followed by a 4 h incubation with 1 ng/mL IL-1b. Luciferase activity was measured using cell lysates. C–D. 832/13
and INS-1E cells were transduced with the aforementioned NF-kB-luc virus. After 24 h, these cells were then exposed to increasing concentrations of
MTA (1, 2, and 4 mM) for 1 h, followed by a 4 h exposure to 1 ng/mL IL-1b. After 4 h, luciferase activity was measured. E. 832/13 cells were cultured in
the presence or absence of increasing concentrations of MTA (0.5, 1, and 2 mM) for 1 h, then switched to either media alone (No Tx) or 1 ng/mL IL-
1b+100 U/mL c-IFN for 6 h, followed by measurement of nitrite accumulation in the media. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0022485.g004
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PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22485Figure 6. Overexpression of the IkBa super-repressor protects against pro-inflammatory cytokines but not genuine apoptotic
induction. A. 832/13 cells were transduced with recombinant adenovirus expressing either b-galactosidase (bGal) or increasing concentrations of
IkBa SR. A. Following 24 h incubation, whole cell lysates were immunoblotted for IkBa with b-actin as a loading control. Immunoblots represent 2
individual experiments. Note that HA-tagging of the IkBa SR causes it to migrate slower (top arrow) relative to the endogenous protein (bottom
arrow). B. 832/13 cells were transduced with NF-kB-luc and either bGAL or the highest dose of the IkBa SR (shown in panel A) for 24 h. Cells were
then treated with 1 ng/mL IL-1b for 4 h and luciferase activity was measured. Data are means 6 SEM for 3 individual experiments. C–D. 832/13 cells
were transduced with adenoviruses expressing either bGAL or increasing concentrations of IkBa. After 24 h, the cells were stimulated with either
1 ng/mL IL-1b or 1 mM STS for 6 h. Nitrite was measured via the Griess assay (C), and viability by MTS assay (D). Values represent means 6 SEM from 4
individual experiments. *, p,0.05.
doi:10.1371/journal.pone.0022485.g006
Figure 5. Pharmacological interference with NF-kB activity protects against cytokine-mediated cell death but not apoptosis. A–B.
832/13 and INS-1E cells were transduced with the NF-kB-luc virus for 24 h, followed by exposure to increasing concentrations of TPCA (0.5, 1, and
2 mM) for 1 h. Luciferase activity was measured following by a subsequent 4 h culture with 1 ng/mL IL-1b. Data are means 6 SE for three
independent experiments, performed in duplicate each time. C–F. 832/13 and INS-1E cells were pre-treated with increasing concentrations of TPCA
(0.5, 1, and 2 mM) for 1 h, followed by a 4 h treatment with either 1 ng/mL IL-1b+100 U/mL c-IFN or 2 mM camptothecin. Nitrite was measured using
the Griess assay (C and D) and viability was measured by MTS assay (E and F). Data are representative of mean 6 SEM for 3–4 individual experiments.
*, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0022485.g005
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22485construct in 832/13 cells suppressed STS-induced cleavage of
caspase-3 (Figure 7A) and also blunted the CPT- and STS-
mediated increases in caspase-3 enzyme activity in a dose-
dependent manner (81 and 74.4% decrease at the highest dose
for CPT and STS, respectively– see Figure 7B and C); this
maneuver has a pronounced impact on cellular structure as viewed
by morphological analysis (Figure 7D). Moreover, the 12.1-fold
increase in caspase-3 enzyme activity by STS in isolated rat islets
was blocked by 64.5% in the presence of C9DN (Figure 7E);
however, the IkBa super-repressor, despite having a strong
repressive effect on cytokine-mediated NF-kB activation
(Figure 6B), did not prevent STS-mediated increases in caspase-
3 activity.
In a complementary approach, siRNA-mediated suppression of
APAF-1 (89%) protected against CPT- and STS-mediated losses
in viability (Figure 7F–I), but had no effect on cellular survival
upon exposure to pro-inflammatory cytokines (Figure 7J and K).
Additionally, expression of C9DN on the background of APAF-1
depletion was additive in protecting against bona fide inducers of
apoptosis (Figure 7H and I). Despite being highly effective against
killing by genuine inducers of apoptosis, extensive interference
with apoptosome activity, via C9DN and siAPAF-1, afforded no
protection against cytokine-mediated cell death (Figure 7J and K).
We interpret these results to indicate that the pro-inflammatory
combination of IL-1b+c-IFN does not impair viability via an
apoptosome requiring mechanism.
Discussion
The recruitment of immune cells to the islets generates insulitis
[47], an inflammatory response with an unknown origin that
eventually produces losses in functional b-cell mass [48,49]. It has
been suggested that during this process, the pro-inflammatory
cytokines IL-1b and c-IFN induce apoptosis in the pancreatic b-
cell [13,50,51]. However, several lines of evidence are not
consistent with apoptosis as the major mechanism of b-cell death
under these conditions. For example, pro-inflammatory cytokines
increase the abundance of iNOS protein, leading to micromolar
amounts of nitric oxide amassing within the b-cell [5,52]; nitric
oxide inhibits formation of the apoptosome complex required for
activation of caspases [37,39,53]. In addition, biochemical and
morphological evidence from direct comparisons of pro-inflam-
matory cytokines and bona fide inducers of apoptosis reveal
differences in cellular death mechanisms activated by these stimuli
[9,11]. Furthermore, overexpression of the anti-apoptotic kinase
Akt or depletion of the pro-apoptotic protein Bax provides
protection against true apoptosis, but not against pro-inflamma-
tory cytokines [11]. Finally, HMGB1, an immunological activating
protein [23], is released in b-cells exposed to IL-1b, but not to the
topoisomerase inhibitor CPT or the general protein kinase
inhibitor STS (both genuine inducers of apoptosis) [9]; activation
of the immune system by necrotic release of immuno-stimulatory
molecules is also consistent with the insulitis and immune cell
recruitment to pancreatic islets that leads to T1DM.
In the present study, we tested the hypothesis that true apoptosis
is distinguishable from cellular death of pancreatic b-cells in
response to pro-inflammatory cytokines. Several novel observa-
tions emerged from the current endeavor: 1) Despite different
selection strategies from the parental INS-1 population, the INS-1-
derived cell lines 832/13 and INS-1E were shown to be equally
sensitive to killing by IL-1b+c-IFN and genuine apoptotic stimuli,
making them excellent models in which to precisely delineate b-
cell death pathways. 2) Discrete metabolic signatures are produced
by pro-inflammatory cytokines as compared to CPT, a bona fide
apoptotic inducer, as measured by tandem mass spectrometry
based metabolomic approach. 3) The metabolite 59-methylthioa-
denosine (MTA) is increased when cells are exposed to CPT but
not IL-1b+c-IFN; direct addition of MTA to b-cell lines inhibits
cytokine-mediated NF-kB activity and nitrite production. 4)
Inhibition of IKKb or overexpression of an IkBa super-repressor
protein blunted cytokine-induced nitric oxide production and
provided protection against losses in b-cell viability; no protection
against CPT-mediated apoptosis was observed using either of
these maneuvers. 5) Manipulation of the apoptosome, via siRNA-
mediated suppression of APAF-1 or a dominant-negative form of
caspase-9, protected against cell death induced by CPT or STS,
but not IL-1b+c-IFN.
We note that the concentrations of the majority of metabolites
measured via mass spectrometry increased in both treatment
conditions. However, this should not necessarily be taken as an
indication that the dying cells are more metabolically active than
the corresponding control since concentration measurements
alone are not sufficient to determine whether a build-up of a
particular metabolite is due to an increase in biosynthesis or to a
decrease in usage of that compound. Nonetheless, the differences
in metabolite signature (Figure 4) between pro-inflammatory
cytokines and bona fide inducers of apoptosis fit with the
distinction in biochemical measurements made in this study and
in previous studies [9,11].
An earlier report proposed a mitochondrial or intrinsic activation
of apoptosis in pancreatic b-cells in response to pro-inflammatory
cytokines [13]. However, no control for genuine apoptosis was used
in those or other recent studies [12,13]. In addition, we note here
that compromised mitochondrial function and release of cyto-
chrome c may not be sufficient for or indicative of apoptosis [54].
For example, in photodynamic treatment of cancer cells, reactive
oxygen species (ROS) accumulate, mitochondrial function is
compromised, cytochrome c is released, yet necrosis occurs
[55,56]. In addition, eliminating the ROS using antioxidants is
protective, while inhibiting ROS scavenging enzymes, such as
superoxide dismutase, enhances cell death [57]. This mechanism is
reminiscent of b-cell death in response to cytokines: ROS levels
accumulate [58,59], mitochondrial function is impaired [60], ATP
levels decrease [11,61], and no detectable markers of apoptosis are
present despite large increases in cell death [9,11]; ROS destroying
enzymes also provide protection against pro-inflammatory cyto-
kines in pancreatic b-cells [62]. Thus, the data do not seem to
support apoptosis as the predominant form of b-cell death in
response to pro-inflammatory cytokines.
Additionally, prior studies using in vivo models of autoimmune-
mediated b-cell death (e.g., NOD mice with cyclophosphamide
accelerated diabetes) found lack of caspase-3 activation in b-cells,
despite the presence of IL-1b [63]. Moreover, transfusion of b-
cells made apoptotic ex vivo prevents Type 1 diabetes in NOD
mice [64]. Also, despite DNA strand breaks (which are not by
themselves markers of apoptosis [18]) in the islets of BB rats,
there is no evidence of apoptosis leading to b-cell destruction
[10]. Furthermore, transgenic expression of the anti-apoptotic
protein Bcl-2 does not prevent losses in pancreatic b-cell mass in
animals with autoimmune forms of diabetes [65]. Collectively,
the aforementioned in vitro and in vivo data, as well as the results in
this report, are all consistent with inflammation leading to
necrotic cell death; this fate of pancreatic b-cells would likely
generate a strong immune response targeted to the insulin-
producing cells, which does occur in individuals with autoim-
mune forms of diabetes, while the available evidence is in favor
of apoptosis being more likely to have the opposite effect
[18,19,23,66].
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PLoS ONE | www.plosone.org 11 July 2011 | Volume 6 | Issue 7 | e22485Figure 7. Manipulation of the apoptosome protects against apoptosis but does not impact pro-inflammatory of cytokine-mediated
cell death. A. 832/13 cells were transduced either with a recombinant adenovirus expressing bGal or dominant-negative caspase 9 for 24 h followed
by a change to media alone (control) or 1 mM staurosporine for 4 h. Whole-cell lysates were immunoblotted for caspase-3 with b-actin as a loading
control. Top and bottom arrows indicate total and cleaved caspase-3, respectively. Immunoblots are representative of two independent experiments.
B and C. 832/13 cells were transduced with either b-Galactosidase or increasing doses of the dominant-negative caspase-9 for 24 h, followed by 4 h
stimulation with either 2 mM camptothecin (B)o r1mM staurosporine (C). Cell lysates were analyzed for caspase-3 enzyme activity and expressed as
percent of the maximal response. Data are presented as mean 6 SEM for three separate experiments. D. The highest dose of Caspase-9 DN from (B
and C) was then used to transduced 832/13 cells. 24 h post-transduction, cells were exposed to 1 mM staurosporine for 4 h, and then phase contrast
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PLoS ONE | www.plosone.org 12 July 2011 | Volume 6 | Issue 7 | e22485Does this mean that apoptosis is absolutely not represented
during pro-inflammatory cytokine-mediated b-cell death? We
suspect that there might be specific, albeit limited, circumstances
in which a subset of pancreatic b-cells may be able to undergo
apoptosis in response to cytokine-mediated damage. For instance,
during the acute (2–24 h) period of cytokine exposure, gene
expression changes are occurring rapidly that lead to the buildup
of inflammatory mediators, such as nitric oxide and prostaglandins,
that are eventually toxic to pancreatic b-cells [67]. During this
period, no detectable markers of apoptosis are apparent (current
study and see [9,11,68]). However, if nitric oxide levels decrease,
presumably to amounts no longer able to inhibit the apoptosome
[37,39], apoptosis may proceed if cellular DNA is unable to be
repaired [68]. Importantly though, sufficient ATP levels must be
present for caspase-mediated cell death, otherwise necrosis will
prevail [11,69]. Therefore, it is quite possible that pro-inflammatory
cytokines preferentially induce a programmed necrotic cell death
(the concept of which has been reviewed recently [70]) with the
possibility for a secondary apoptotic event only under specific
conditions (Figure 8). Indeed, the necrotic program initiated by pro-
inflammatory cytokines may actually actively suppress apoptosis via
the mechanisms described above, much like apoptotic signaling
proteins can prevent necrosis [71,72,73]. We also note that the role
of autophagy, another regulated form of cellular demise that can be
linked with inflammation in response to c-IFN [74], is largely
unexplored in the pancreatic b-cell. However, since autophagy may
play a role in maintenance of islet function during insulin resistance
[75] as well as islet graft malfunction [76], its role in both major
forms of diabetes should be considered alongside programmed
cellular necrosis.
In summary, we demonstrated here that induction of apoptosis
by CPT and STS is rapid (Figures 1–3), consistent with general
descriptions of this cellular death mechanism (for reviews, see
[15,77]). Furthermore, interference with the apoptosome by
siAPAF-1 and caspase-9 dominant-negative approaches protected
against known apoptotic agents, but not pro-inflammatory
cytokines. On the other hand, established strategies for blocking
NF-kB activity were highly effective against pro-inflammatory
cytokines but not apoptotic induction (Figures 5 and 6). Taken
together, these observations fit with the distinct metabolic profiles
generated by these two different b-cell death-inducing stimuli (See
heatmap – Figure 4A and Tables S1 and S2). Thus, interfering with
signaling to NF-kBt h r o u g hI K K b or the IkBa super-repressor (see
Figures 5 and 6 and [78]) offered robust protection against cytokine-
mediated b-cell death, while maneuvers that impact apoptosis, such
as constitutively-active Akt or siRNA-mediated suppression of Bax
[11], or manipulation of the apoptosome (Figure 7) provide
protection against authentic apoptotic signals. In addition, it is likely
that some of the inflammatory actions of IL-1b are mediated
through the IKKs [79]. Therefore, inhibition of the IKKs, such as
with TPCA (Figure 5) or by peptide inhibitors [80] is a reasonable
strategy to offset death and dysfunction mediated by pro-
inflammatory cytokines. Based on results presented herein and
those of other extant studies, we conclude that b-cell fate in response
to pro-inflammatory is unlikely to proceed through an apoptotic
pathway.
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Figure 8. Cell death pathways activated in pancreatic b-cells in response to pro-inflammatory or apoptotic stimuli. The combination
of IL-1b+c-IFN generates massive quantities of nitric oxide within the pancreatic b-cell which impairs b-cell function, decreases intracellular ATP levels,
and inhibits apoptosome formation and/or activity, leading to cellular death by necrosis. Apoptotic signals, such as camptothecin, lead to DNA
damage without nitric oxide accumulation, which signals apoptosome formation. Nitric oxide inhibits apoptosome activity but also damages DNA,
which the cell attempts to repair. If the damaged DNA cannot be repaired and nitric oxide levels decrease sufficiently to allow apoptosome
formation, a subset of b-cells may undergo apoptosis provided adequate ATP levels are present.
doi:10.1371/journal.pone.0022485.g008
images were acquired. E. Rat islets were transduced with the indicated adenoviruses; 72 h after adenoviral transduction, the islets were exposed to
10 ng/mL IL-1b or 1 mM staurosporine for 6 h and harvested for caspase-3 enzyme activity. F-K. 832/13 cells were transduced with recombinant
adenoviruses expressing either bGAL or Caspase-9 DN. After 8 h of incubation with the indicated adenoviruses, cells were then transfected with
siRNA duplexes representing either a scrambled control (siScramble) or specifically targeting the APAF-1 mRNA. 24 h after siRNA transfection, cells
were treated with either 2 mM camptothecin (F and H)o r1mM staurosporine (G and I) for 4 h or 1 ng/mL IL-1b+100 U/mL c-IFN for 18 h (J and K). *,
p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0022485.g007
Mechanisms of Pancreatic b-Cell Death
PLoS ONE | www.plosone.org 13 July 2011 | Volume 6 | Issue 7 | e22485Author Contributions
Conceived and designed the experiments: JJC SJB SRC. Performed the
experiments: JJC SJB MEE DL RCS CJF SRC. Analyzed the data: JJC
SJB MEE DL RCS CJF SRC. Contributed reagents/materials/analysis
tools: JJC SJB MEE DL SRC. Wrote the paper: JJC SJB MEE SRC.
References
1. Mathis D, Vence L, Benoist C (2001) beta-Cell death during progression to
diabetes. Nature 414: 792–798.
2. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of
IDDM. Diabetologia 39: 1005–1029.
3. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, et al. (1998)
IL-1 produced and released endogenously within human islets inhibits beta cell
function. J Clin Invest 102: 516–526.
4. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, Jr., McDaniel ML (1993)
Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human
islets of Langerhans. Proc Natl Acad Sci U S A 90: 1731–1735.
5. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, Jr., McDaniel ML (1992)
Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified
from rodent islets of Langerhans. Evidence for the beta-cell as a source and site
of action of nitric oxide. J Clin Invest 90: 2384–2391.
6. Rabinovitch A, Pukel C, Baquerizo H (1988) Interleukin-1 inhibits glucose-
modulated insulin and glucagon secretion in rat islet monolayer cultures.
Endocrinology 122: 2393–2398.
7. Pukel C, Baquerizo H, Rabinovitch A (1988) Destruction of rat islet cell
monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor
necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133–136.
8. Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgensen DW, et al.
(1987) Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet
donor characteristics. Diabetes 36: 641–647.
9. Steer SA, Scarim AL, Chambers KT, Corbett JA (2006) Interleukin-1 stimulates
beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS
Med 3: e17.
10. Fehsel K, Kolb-Bachofen V, Kroncke KD (2003) Necrosis is the predominant
type of islet cell death during development of insulin-dependent diabetes mellitus
in BB rats. Lab Invest 83: 549–559.
11. Collier JJ, Fueger PT, Hohmeier HE, Newgard CB (2006) Pro- and
antiapoptotic proteins regulate apoptosis but do not protect against cytokine-
mediated cytotoxicity in rat islets and beta-cell lines. Diabetes 55: 1398–1406.
12. Gurzov EN, Germano CM, Cunha DA, Ortis F, Vanderwinden JM, et al. (2010)
p53 up-regulated modulator of apoptosis (PUMA) activation contributes to
pancreatic beta-cell apoptosis induced by proinflammatory cytokines and
endoplasmic reticulum stress. J Biol Chem 285: 19910–19920.
13. Grunnet LG, Aikin R, Tonnesen MF, Paraskevas S, Blaabjerg L, et al. (2009)
Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells.
Diabetes 58: 1807–1815.
14. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer
26: 239–257.
15. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the
cellular level. Nat Rev Mol Cell Biol 9: 231–241.
16. Wang C, Youle RJ (2009) The role of mitochondria in apoptosis*. Annu Rev
Genet 43: 95–118.
17. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997)
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex
initiates an apoptotic protease cascade. Cell 91: 479–489.
18. Zong WX, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20:
1–15.
19. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous
activators of dendritic cells. Nat Med 5: 1249–1255.
20. Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases.
J Clin Invest 107: 7–11.
21. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell
132: 344–362.
22. Baldwin AS, Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries
and insights. Annu Rev Immunol 14: 649–683.
23. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1
by necrotic cells triggers inflammation. Nature 418: 191–195.
24. Krysko DV, Denecker G, Festjens N, Gabriels S, Parthoens E, et al. (2006)
Macrophages use different internalization mechanisms to clear apoptotic and
necrotic cells. Cell Death Differ 13: 2011–2022.
25. Shi Y, Zheng W, Rock KL (2000) Cell injury releases endogenous adjuvants that
stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A 97:
14590–14595.
26. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, et al. (2000)
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-
dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:
424–430.
27. Janjic D, Maechler P, Sekine N, Bartley C, Annen AS, et al. (1999) Free radical
modulation of insulin release in INS-1 cells exposed to alloxan. Biochem
Pharmacol 57: 639–648.
28. Collier JJ, Doan TT, Daniels MC, Schurr JR, Kolls JK, et al. (2003) c-Myc is
required for the glucose-mediated induction of metabolic enzyme genes. J Biol
Chem 278: 6588–6595.
29. Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, et al. (1998) Inhibition
of proinflammatory molecule production by adenovirus-mediated expression of
a nuclear factor kappaB super-repressor in human intestinal epithelial cells.
J Immunol 160: 410–418.
30. Liang Q, Liou AK, Ding Y, Cao G, Xiao X, et al. (2004) 6-Hydroxydopamine
induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic
pathway that is attenuated by caspase-9dn expression. J Neurosci Res 77:
747–761.
31. Haycock JW (1993) Polyvinylpyrrolidone as a blocking agent in immunochem-
ical studies. Anal Biochem 208: 397–399.
32. Waters CM, Lu W, Rabinowitz JD, Bassler BL (2008) Quorum sensing controls
biofilm formation in Vibrio cholerae through modulation of cyclic di-GMP levels
and repression of vpsT. J Bacteriol 190: 2527–2536.
33. Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, et al. (2006) Separation and
quantitation of water soluble cellular metabolites by hydrophilic interaction
chromatography-tandem mass spectrometry. J Chromatogr A 1125: 76–88.
34. Saldanha AJ (2004) Java Treeview–extensible visualization of microarray data.
Bioinformatics 20: 3246–3248.
35. Asfari M, Janjic D, Meda P, Li G, Halban PA, et al. (1992) Establishment of 2-
mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocri-
nology 130: 167–178.
36. Maedler K, Schumann DM, Sauter N, Ellingsgaard H, Bosco D, et al. (2006)
Low concentration of interleukin-1beta induces FLICE-inhibitory protein-
mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:
2713–2722.
37. Zech B, Kohl R, von Knethen A, Brune B (2003) Nitric oxide donors inhibit
formation of the Apaf-1/caspase-9 apoptosome and activation of caspases.
Biochem J 371: 1055–1064.
38. Li J, Bombeck CA, Yang S, Kim YM, Billiar TR (1999) Nitric oxide suppresses
apoptosis via interrupting caspase activation and mitochondrial dysfunction in
cultured hepatocytes. J Biol Chem 274: 17325–17333.
39. Kim YM, Talanian RV, Billiar TR (1997) Nitric oxide inhibits apoptosis by
preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol
Chem 272: 31138–31148.
40. Hughes KJ, Meares GP, Chambers KT, Corbett JA (2009) Repair of nitric
oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha
expression. J Biol Chem 284: 27402–27408.
41. Eng WK, Faucette L, Johnson RK, Sternglanz R (1988) Evidence that DNA
topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol
Pharmacol 34: 755–760.
42. Ignarro LJ (1996) Physiology and pathophysiology of nitric oxide. Kidney Int
Suppl 55: S2–5.
43. Avila MA, Garcia-Trevijano ER, Lu SC, Corrales FJ, Mato JM (2004)
Methylthioadenosine. Int J Biochem Cell Biol 36: 2125–2130.
44. Ea CK, Baltimore D (2009) Regulation of NF-kappaB activity through lysine
monomethylation of p65. Proc Natl Acad Sci U S A 106: 18972–18977.
45. Podolin PL, Callahan JF, Bolognese BJ, Li YH, Carlson K, et al. (2005)
Attenuation of murine collagen-induced arthritis by a novel, potent, selective
small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)a-
mino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of
proinflammatory cytokines and antigen-induced T cell Proliferation.
J Pharmacol Exp Ther 312: 373–381.
46. Hu Y, Benedict MA, Ding L, Nunez G (1999) Role of cytochrome c and dATP/
ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J
18: 3586–3595.
47. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, et al. (2002) Beta cells are
responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8:
1414–1420.
48. Ziegler AG, Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS (1990)
Predicting type I diabetes. Diabetes Care 13: 762–765.
49. Kolb H, Burkart V, Appels B, Hanenberg H, Kantwerk-Funke G, et al. (1990)
Essential contribution of macrophages to islet cell destruction in vivo and in
vitro. J Autoimmun 3 Suppl 1: 117–120.
50. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, et al. (2001)
Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated
expression of a NF-kappaB super-repressor prevents beta-cell apoptosis.
Diabetes 50: 2219–2224.
51. Eizirik DL, Darville MI (2001) beta-cell apoptosis and defense mechanisms:
lessons from type 1 diabetes. Diabetes 50 Suppl 1: S64–69.
52. Corbett JA, McDaniel ML (1992) Does nitric oxide mediate autoimmune
destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes
41: 897–903.
Mechanisms of Pancreatic b-Cell Death
PLoS ONE | www.plosone.org 14 July 2011 | Volume 6 | Issue 7 | e2248553. Melino G, Catani MV, Corazzari M, Guerrieri P, Bernassola F (2000) Nitric
oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci 57:
612–622.
54. KushnarevaY,NewmeyerDD(2010)Bioenergeticsandcelldeath.AnnNYAcad
Sci 1201: 50–57.
55. Almeida RD, Manadas BJ, Carvalho AP, Duarte CB (2004) Intracellular
signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704:
59–86.
56. Whitacre CM, Satoh TH, Xue L, Gordon NH, Oleinick NL (2002)
Photodynamic therapy of human breast cancer xenografts lacking caspase-3.
Cancer Lett 179: 43–49.
57. Golab J, Nowis D, Skrzycki M, Czeczot H, Baranczyk-Kuzma A, et al. (2003)
Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestra-
diol. A superoxide dismutase inhibitor. J Biol Chem 278: 407–414.
58. Horio F, Fukuda M, Katoh H, Petruzzelli M, Yano N, et al. (1994) Reactive
oxygen intermediates in autoimmune islet cell destruction of the NOD mouse
induced by peritoneal exudate cells (rich in macrophages) but not T cells.
Diabetologia 37: 22–31.
59. Chen J, Gusdon AM, Thayer TC, Mathews CE (2008) Role of increased ROS
dissipation in prevention of T1D. Ann N Y Acad Sci 1150: 157–166.
60. Scarim AL, Heitmeier MR, Corbett JA (1997) Irreversible inhibition of
metabolic function and islet destruction after a 36-hour exposure to
interleukin-1beta. Endocrinology 138: 5301–5307.
61. Meredith M, Rabaglia ME, Corbett JA, Metz SA (1996) Dual functional effects
of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and
INS-1 cells. Diabetes 45: 1783–1791.
62. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB (1998) Stable
expression of manganese superoxide dismutase (MnSOD) in insulinoma cells
prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production.
J Clin Invest 101: 1811–1820.
63. Reddy S, Bradley J, Ross JM (2003) Immunolocalization of caspase-3 in
pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes.
Ann N Y Acad Sci 1005: 192–195.
64. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, et al. (2007) Transfusion of
apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents
type 1 diabetes in NOD mice. Diabetes 56: 2116–2123.
65. Allison J, Thomas H, Beck D, Brady JL, Lew AM, et al. (2000) Transgenic
overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not
prevent autoimmune destruction. Int Immunol 12: 9–17.
66. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, et al. (1997)
Immunosuppressive effects of apoptotic cells. Nature 390: 350–351.
67. McDaniel ML, Corbett JA, Kwon G, Hill JR (1997) A role for nitric oxide and
other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunc-
tion and destruction. Adv Exp Med Biol 426: 313–319.
68. Hughes KJ, Chambers KT, Meares GP, Corbett JA (2009) Nitric oxides
mediates a shift from early necrosis to late apoptosis in cytokine-treated {beta}-
cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol
Metab.
69. Nicotera P, Melino G (2004) Regulation of the apoptosis-necrosis switch.
Oncogene 23: 2757–2765.
70. Moquin D, Chan FK (2010) The molecular regulation of programmed necrotic
cell injury. Trends Biochem Sci 35: 434–441.
71. Zhang H, Zhou X, McQuade T, Li J, Chan FK, et al. (2011) Functional
complementation between FADD and RIP1 in embryos and lymphocytes.
Nature 471: 373–376.
72. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, et al. (2011)
Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent
necrosis. Nature 471: 363–367.
73. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, et al.
(2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice.
Nature 471: 368–372.
74. Chang YP, Tsai CC, Huang WC, Wang CY, Chen CL, et al. (2010) Autophagy
facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflamma-
tion. J Biol Chem 285: 28715–28722.
75. Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, et al. (2008) Autophagy
is important in islet homeostasis and compensatory increase of beta cell mass in
response to high-fat diet. Cell Metab 8: 325–332.
76. Tanemura M, Saga A, Kawamoto K, Machida T, Deguchi T, et al. (2009)
Rapamycin induces autophagy in islets: relevance in islet transplantation.
Transplant Proc 41: 334–338.
77. Schwartzman RA, Cidlowski JA (1993) Apoptosis: the biochemistry and
molecular biology of programmed cell death. Endocr Rev 14: 133–151.
78. Giannoukakis N, Rudert WA, Trucco M, Robbins PD (2000) Protection of
human islets from the effects of interleukin-1beta by adenoviral gene transfer of
an Ikappa B repressor. J Biol Chem 275: 36509–36513.
79. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109
Suppl: S81–96.
80. Rehman KK, Bertera S, Bottino R, Balamurugan AN, Mai JC, et al. (2003)
Protection of islets by in situ peptide-mediated transduction of the Ikappa B
kinase inhibitor Nemo-binding domain peptide. J Biol Chem 278: 9862–9868.
Mechanisms of Pancreatic b-Cell Death
PLoS ONE | www.plosone.org 15 July 2011 | Volume 6 | Issue 7 | e22485